Michel Finance

Michel Finance currently works at Holding Incubatrice Biotechnologie, as Chairman & Chief Executive Officer, Prestizia SASU, as Chairman, France Biotech Association, as Director from 2006, and Truffle Capital SAS, as Venture Partner from 2010.
Mr. Finance also formerly worked at Theradiag SA, as CEO, Director & Head-Investor Relations in 2013, Zophis SASU, as Chairman, Biokinesis SAS, as Chairman, Affluent Medical SA, as Executive Chairman from 2022 to 2023, Flamel Technologies SA, as Deputy Managing Director in 2008, Sanofi, as Financial Director, Neovacs SA, as Executive Director from 2009 to 2015, Carmat SA, as Independent Director from 2008 to 2015, Aventis, Inc., as Controller & Senior Vice President, and PricewaterhouseCoopers Audit SA, as Financial Auditor.
Mr. Finance received his undergraduate degree from EM Lyon Business School.